Everolimus in patients with advanced pancreatic neuroendocrine tumors (pNET): Impact of somatostatin analog use on progression-free survival in the RADIANT-3 trial.
Manisha Shah
Honoraria - Novartis
Research Funding - ImClone Systems; Novartis
Catherine Lombard-Bohas
No relevant relationships to disclose
Tetsuhide Ito
No relevant relationships to disclose
Edward Wolin
Consultant or Advisory Role - Novartis
Eric Van Cutsem
Research Funding - Novartis
Carolin Sachs
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Robert Winkler
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Jeremie Lincy
Employment or Leadership Position - Novartis
Timothy Hobday
Consultant or Advisory Role - Novartis
Research Funding - Novartis
James Yao
Consultant or Advisory Role - Endo Pharmaceuticals; Ipsen; Novartis; Pfizer
Honoraria - Novartis
Research Funding - Genentech; Novartis